Cargando…
Using the best available data to estimate the cost of antimicrobial resistance: a systematic review
BACKGROUND: Valuation of the economic cost of antimicrobial resistance (AMR) is important for decision making and should be estimated accurately. Highly variable or erroneous estimates may alarm policy makers and hospital administrators to act, but they also create confusion as to what the most reli...
Autores principales: | Wozniak, Teresa M., Barnsbee, Louise, Lee, Xing J., Pacella, Rosana E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6359818/ https://www.ncbi.nlm.nih.gov/pubmed/30733860 http://dx.doi.org/10.1186/s13756-019-0472-z |
Ejemplares similares
-
Letter to the editor in response to estimating the burden of antimicrobial resistance: a systematic literature review
por: Wozniak, Teresa M.
Publicado: (2018) -
Cost-effectiveness of Ruxolitinib vs Best Available Therapy in the Treatment of Myelofibrosis in Spain
por: Gómez-Casares, María Teresa, et al.
Publicado: (2017) -
Cost-effectiveness analysis of an innovative model of care for chronic wounds patients
por: Brain, David, et al.
Publicado: (2019) -
Estimating the fitness cost and benefit of antimicrobial resistance from pathogen genomic data
por: Helekal, David, et al.
Publicado: (2023) -
COVID-19 treatment in sub-Saharan Africa: If the best is not available, the available becomes the best
por: Dubbink, Jan H, et al.
Publicado: (2020)